Pharmacoscintigraphy confirms consistent tamsulosin release from a novel triple-layered tablet

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 41-46

  Hodges, L A ^a   Sime, K A ^a   Creech, L A ^a   Connolly, S M ^a   Barclay, S T ^a   Kwon, Min Chang ^b   Jeon, Byeong Jin ^b   Shim, Sang Min ^b   Wang, Hun Sik ^b   Stevens, H N E ^a   Park, Jun Sang ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b GL PharmTech Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE ACETATE; CHARCOAL; TAMSULOSIN; TECHNETIUM 99M;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASCENDING COLON; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; DESCENDING COLON; DOSIMETRY; DRUG ABSORPTION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DUMPING SYNDROME; GAMMA SCINTIGRAPHY; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; GEOMETRICALLY LONG ABSORPTION REGULATED SYSTEM TABLET; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; ISOTOPE LABELING; MALE; NORMAL HUMAN; PHARMACOKINETICS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STOMACH; STOMACH EMPTYING; STOMACH SCINTISCANNING; TABLET; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TRANSVERSE COLON; UNSPECIFIED SIDE EFFECT; VOLUNTEER;

EID: 84884153543     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.065     Document Type: Article

References (17)

1. Davis, S.S., Hardy, J.G., Fara, J.W., 1986. Transit of pharmaceutical dosage forms through the small intestine. Gut 27, 886-892. (Pubitemid 16044258)
2. Davis, S.S., Hardy, J.G., Newman, S.P., Wilding, I.R., 1992. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 19, 971-986.
3. Djavan, B., Milani, S., Davies, J., Bolodeoku, J., 2005. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study. Eur. Urol. Suppl. 4, 61-68. (Pubitemid 40125738)
4. Ford, J.L., Rubenstein, M.H., Hogan, J.E., 1985. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices. Int. J. Pharm. 24, 327-338. (Pubitemid 15062540)
5. Ford, J.L., Mitchell, K., Rowe, P., Armstrong, D.J., Elliott, P.N.C., Rostron, C., Hogan, J.E., 1991. Mathematical modeling of drug release from hydroxypropylmethylcellulose matrices: effect of temperature. Int. J. Pharm. 71, 95-104.
6. Huang, X., Brazel, C.S., 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J. Control. Release 73, 121-136. (Pubitemid 32539245)
7. Lyseng-Williamson, K.A., Jarvis, B., Wagstaff, A.J., 2002. Tamsulosin: an update of its role in the management of lower urinary tract symptoms. Drugs 62, 135-167. (Pubitemid 34169429)
8. Michel, M.C., Korstanje, C., Krauwinkel, W., 2005a. Cardiovascular safety of tamsulosin modified release in the fasting and fed state in elderly healthy subjects. Eur. Urol. Suppl. 4, 9-14. (Pubitemid 40125733)
9. Michel, M.C., Korstanje, C., Krauwinkel, W., Shear, M., Davies, J., Quartel, A., 2005b. Comparison of vascular α1-adrenoceptor antagonism of tamsulosin in oral controlled absorption system (OCAS) and modified release (MR) formulations. Eur. Urol. Suppl. 4, 45-52. (Pubitemid 40125736)
10. Michel, M.C., Korstanje, C., Krauwinkel, W., Shear, M., Davies, J., Quartel, A., 2005c. Cardiovascular safety of the oral controlled absorption system (OCAS) formulation of tamsulosin compared to the modified release (MR) formulation. Eur. Urol. Suppl. 4, 53-60. (Pubitemid 40125737)
11. Michel, M.C., Korstanje, C., Krauwinkel, W., Kuipers, M., 2005d. The pharmacokinetic profile of tamsulosin oral controlled absorption system (OCAS). Eur. Urol. Suppl. 4, 15-24. (Pubitemid 40125734)
12. Park, J.S., Shim, J.Y., Park, J.S., Lee, M.J., Kang, J.M., Lee, S.H., Kwon, M.C., Choi, Y.W., Jeong, S.H., 2011a. Formulation variation and in vitro-in vivo correlation for a rapidly swellable three-layered tablet of tamsulosin HCl. Chem. Pharm. Bull. 59, 529-535.
13. Park, J.S., Shim, J.Y., Park, J.S., Choi, Y.W., Jeong, S.H., 2011b. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles. Drug Dev. Ind. Pharm. 37, 664-672.
14. Ranga Rao, K.V., Padmalatha Devi, K., Buri, P., 1990. Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. J. Control. Release 12, 133-141. (Pubitemid 20123878)
15. Siepmann, J., Peppas, N.A., 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48, 139-157. (Pubitemid 32434400)
16. Stevens, H.N.E., Speakman, M., 2006. Behaviour and transit of tamsulosin oral controlled absorption system in the gastrointestinal tract. Curr. Med. Res. Opin. 22, 2323-2328. (Pubitemid 46048348)
17. Wagner, J.O., 1983. The Wagner-Nelson method applied to a multicompartment model with zero order input. Biopharm. Drug Dispos. 4, 359-373.